Skip to main content
Premium Trial:

Request an Annual Quote

Diversa, JGI Team on Microbial Sequencing Project

NEW YORK, May 5 - Microbial genomics firm Diversa said today that it is collaborating with the US Department of Energy's Joint Genome Institute to discover and sequence novel microbial genomes found in a range of environmental conditions.


Diversa will extract DNA from environmental samples and make gene libraries, while JGI will sequence the genomes of the organisms.


All sequence data from the collaboration will be provided to Diversa and will also be deposited in GenBank within six months of the completion of sequencing, Diversa said.


Diversa and JGI said they would sequence DNA from microbes living in a number of extreme environments, including deep-sea thermal vents, soil from nuclear weapons manufacturing sites, and water collected by rainforest epiphytes - organisms that grow on the outer surface of trees.


Diversa claims that its gene libraries currently contain the complete genomes of over three million unique microorganisms.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.